Our Newborn and Infant Chronic Lung Disease Program was designated a Frontier Program by Children's Hospital of Philadelphia in 2017. Frontier Programs are unique, cutting-edge programs that will forge important new discoveries, deliver novel therapies, and help even more children thrive.
In addition to our own CLD research, CHOP’s Newborn and Infant Chronic Lung Disease Program participates in the BPD Collaborative, a multi-institution group dedicated to filling knowledge gaps around the care of infants with BPD.